Wells Fargo
KMTS

Wells Fargo’s Kestra Medical Technologies KMTS Stock Holding History

Wells Fargo’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$211K Sell
10,595
-11,753
-53% -$277K ﹤0.01% 4677
2025
Q4 		$593K Buy
22,348
+13,325
+148% +$343K ﹤0.01% 4363
2025
Q3 		$214K Buy
9,023
+1,326
+17% +$23.7K ﹤0.01% 4899
2025
Q2 		$128K Buy
7,697
+6,997
+1,000% +$153K ﹤0.01% 5056
2025
Q1 		$17.4K Buy
+700
New +$16.1K ﹤0.01% 5750

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $177M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wells Fargo's KMTS Position: Q1 2026 in Review

Wells Fargo reduced its Kestra Medical Technologies (KMTS) stake by 53% in Q1 2026, selling an estimated $277K and leaving 10,595 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #4677.

Wells Fargo first reported a position in KMTS in Q1 2025 and has held it in 5 quarters since. The position peaked at $593K in Q4 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Wells Fargo held 10,595 shares of Kestra Medical Technologies worth $211K as of Q1 2026.
  • Wells Fargo sold 11,753 Kestra Medical Technologies shares in Q1 2026, an estimated $277K.
  • Kestra Medical Technologies made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4677 holding.
  • Wells Fargo first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 5 quarters since.
  • Wells Fargo's Kestra Medical Technologies position peaked at $593K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.